Tuesday, August 1, 2017

Mavyret is now Approved in Europe


Mavyret is NS3/4A protease inhibitor made of GLECPREVIR 300mg and NS5A inhibitor PIBRENTASVIR (120mg).



GLECPREVIR & PIBRENTASVIR is a once daily treatment consisting of 3 tablets for 8 weeks, with genotypes 1-6.

Mavyret is not yet available in India as of yet.
There have been no talks of this drug being manufactured in India as of yet.  The funny thing is people in India are importing this medicine from the US.  Only the real rich Indian people that can afford $16,778.  For majority, like around 99% of Indians cannot afford this medicine at all.  The few Indians that can afford it, it will be a huge benefit. 

Some genotypes do not respond to Harvoni, Sovaldi, Epclusa or Daklinza.  This is where Mavyret comes in to play and helps cure hepatitis C. 

In the mean time we want to wish all those with hepatitis C to be cured.  In a very short time in the future, we will see a world without hepatitis C. 

If you need hepatitis C treatment that is affordable, contact hcvmeds@gmail.com or visit our website SunnyPharma.info  You can also give us a call 24/7 at 858-952-1077.